Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-3179
Title: Letter to the editor: newer-generation antidepressants and suicide risk in randomized controlled trials : a re-analysis of the FDA database
Authors : Hengartner, Michael Pascal
Plöderl, Martin
et. al : No
Published in : Psychotherapy and psychosomatics
Volume(Issue) : 88
Issue : 4
Pages : 247
Pages to: 248
Publisher / Ed. Institution : Karger
Issue Date: 24-Jun-2019
License (according to publishing contract) : CC BY-NC-ND 4.0: Attribution - Non commercial - No derivatives 4.0 International
Type of review: Peer review (Publication)
Language : English
Subject (DDC) : 616.89: Mental disorders, clinical psychology and psychiatry
Departement: Applied Psychology
Organisational Unit: Psychological Institute (PI)
Publication type: Article in scientific Journal
DOI : 10.21256/zhaw-3179
10.1159/000501215
ISSN: 0033-3190
1423-0348
URI: https://digitalcollection.zhaw.ch/handle/11475/17418
Appears in Collections:Publikationen Angewandte Psychologie

Files in This Item:
File Description SizeFormat 
Re-analysis FDA suicide data.pdfPaper93.66 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.